MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 118 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,403,500 | +131.8% | 41,050 | +70.3% | 0.00% | – |
| Q1 2024 | $605,392 | -36.3% | 24,100 | -25.2% | 0.00% | – |
| Q4 2023 | $950,603 | -22.5% | 32,202 | -17.1% | 0.00% | -100.0% |
| Q3 2023 | $1,227,218 | +32.5% | 38,836 | +8.5% | 0.00% | – |
| Q2 2023 | $926,198 | +60.0% | 35,802 | +48.6% | 0.00% | – |
| Q1 2023 | $578,882 | +23.2% | 24,100 | 0.0% | 0.00% | – |
| Q4 2022 | $469,950 | +8.5% | 24,100 | +17.0% | 0.00% | – |
| Q3 2022 | $433,000 | +8.0% | 20,600 | 0.0% | 0.00% | – |
| Q2 2022 | $401,000 | -11.7% | 20,600 | 0.0% | 0.00% | – |
| Q1 2022 | $454,000 | +38.0% | 20,600 | 0.0% | 0.00% | – |
| Q4 2021 | $329,000 | -1.2% | 20,600 | +23.4% | 0.00% | – |
| Q3 2021 | $333,000 | +15.2% | 16,700 | 0.0% | 0.00% | – |
| Q2 2021 | $289,000 | -2.0% | 16,700 | +12.1% | 0.00% | – |
| Q1 2021 | $295,000 | +13.5% | 14,900 | 0.0% | 0.00% | – |
| Q4 2020 | $260,000 | +0.8% | 14,900 | +11.2% | 0.00% | – |
| Q3 2020 | $258,000 | -1.1% | 13,400 | 0.0% | 0.00% | – |
| Q2 2020 | $261,000 | -97.7% | 13,400 | -98.8% | 0.00% | -100.0% |
| Q3 2019 | $11,517,000 | – | 1,144,813 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,495,392 | $222,077,452 | 10.39% |
| BOONE CAPITAL MANAGEMENT LLC | 523,679 | $17,904,585 | 4.67% |
| TANG CAPITAL MANAGEMENT LLC | 1,287,107 | $44,006,188 | 4.48% |
| BVF INC/IL | 4,370,024 | $149,411,121 | 4.19% |
| First Turn Management, LLC | 703,398 | $24,049,178 | 3.91% |
| Nan Fung Group Holdings Ltd | 106,100 | $3,627,559 | 3.87% |
| Prosight Management, LP | 314,800 | $10,763,012 | 3.22% |
| Novo Holdings A/S | 1,500,000 | $51,285,000 | 2.98% |
| Lion Point Capital, LP | 45,000 | $1,538,550 | 2.80% |
| Highlander Partners, L.P. | 122,980 | $4,204,686 | 2.80% |